Skip to content
10-K

Annual Report

Whitehawk Therapeutics, Inc. WHWK

0001193125-26-104158

← back to feed
Filed
Mar 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 9, 2026 47.2M sh
Shares Diluted FY 2025 · Dec 31, 2025 61.89M sh
Shares Diluted FY 2025 · Dec 31, 2024 27.03M sh
Capex FY 2025 · Dec 31, 2025 $552K
Capex FY 2025 · Dec 31, 2024 $1.65M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$97.43M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$59.55M
Short Term Investments FY 2025 · Dec 31, 2025 $108.13M
Short Term Investments FY 2025 · Dec 31, 2024 $18.57M
Cash And Equivalents FY 2025 · Dec 31, 2025 $37.57M
Cash And Equivalents FY 2025 · Dec 31, 2024 $28.67M
Stockholders Equity FY 2025 · Dec 31, 2025 $136.31M
Stockholders Equity FY 2025 · Dec 31, 2024 $52.48M
Stockholders Equity FY 2025 · Dec 31, 2023 $105.2M
Current Liabilities FY 2025 · Dec 31, 2025 $14.52M
Current Liabilities FY 2025 · Dec 31, 2024 $17.07M
Total Liabilities FY 2025 · Dec 31, 2025 $14.52M
Total Liabilities FY 2025 · Dec 31, 2024 $17.84M
Current Assets FY 2025 · Dec 31, 2025 $149.01M
Current Assets FY 2025 · Dec 31, 2024 $61.29M
Total Assets FY 2025 · Dec 31, 2025 $150.83M
Total Assets FY 2025 · Dec 31, 2024 $70.32M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.33
Eps Diluted FY 2025 · Dec 31, 2024 −$2.36
Eps Basic FY 2025 · Dec 31, 2025 −$0.33
Eps Basic FY 2025 · Dec 31, 2024 −$2.36
Sga Expense FY 2025 · Dec 31, 2025 $29.82M
Sga Expense FY 2025 · Dec 31, 2024 $36.75M
Rd Expense FY 2025 · Dec 31, 2025 $90.96M
Rd Expense FY 2025 · Dec 31, 2024 $51.03M
Net Income FY 2025 · Dec 31, 2025 −$20.6M
Net Income FY 2025 · Dec 31, 2024 −$63.69M
Operating Income FY 2025 · Dec 31, 2025 −$114.4M
Operating Income FY 2025 · Dec 31, 2024 −$67.46M
Cost Of Revenue FY 2025 · Dec 31, 2025 $760K
Cost Of Revenue FY 2025 · Dec 31, 2024 $3.02M
Revenue FY 2025 · Dec 31, 2025 $7.15M
Revenue FY 2025 · Dec 31, 2024 $25.98M